SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-040250
Filing Date
2021-10-14
Accepted
2021-10-14 16:48:15
Documents
2
Period of Report
2021-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1586
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3800
  Complete submission text file 0000899243-21-040250.txt   6913
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address
Tregoning Kathleen (Reporting) CIK: 0001830764 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38266 | Film No.: 211323749